Efficacy and safety of insulin glargine/lixisenatide (iGlarLixi) fixed-ratio combination in older adults with type 2 diabetes
Author:
Funder
Sanofi
Publisher
Elsevier BV
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference27 articles.
1. Diabetes in older adults;Kirkman;Diabetes Care,2012
2. Management of type 2 diabetes mellitus in older patients: current and emerging treatment options;Moghissi;Diabetes Ther,2013
3. Standards of medical care in diabetes—2018;American Diabetes Association;Diabetes Care,2018
4. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010;Stark Casagrande;Diabetes Care,2013
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. THE EFFECT OF DIABETES SELF MANAGEMENT EDUCATION (DSME) ON SELF EFFICACY IN TYPE II DIABETES MELLITUS PATIENTS;Nurse and Health: Jurnal Keperawatan;2024-06-28
2. Guideline for the Management of Diabetes Mellitus in the Elderly in China (2024 Edition);AGING MEDICINE;2024-02
3. Effects of age and disease duration on the efficacy and safety of iGlarLixi in Asian people with type 2 diabetes: A post hoc analysis of the LixiLan‐O‐AP and LixiLan‐L‐CN trials;Diabetes, Obesity and Metabolism;2024-01-03
4. Advancing type 2 diabetes therapy with iGlarLixi in older people: Pooled analysis of four randomized controlled trials;Diabetes, Obesity and Metabolism;2023-12-11
5. Budget Impact Analysis of Intensification with iGlarLixi Compared to Alternative Treatment Strategies Among Patients with Type 2 Diabetes Mellitus;Diabetes Therapy;2023-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3